Riccardo Bigi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Riccardo Bigi has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Lauro Cortigiani
Divisione di Cardiologia, Ospedale "Campo di Marte", Lucca, Italy
9 shared publicationsCesare Fiorentini
6 shared publications- Dario Gregori
Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, 35121 Padua, Italy
6 shared publications - Lauro Cortigiani
Division of Cardiology, San Luca Hospital, 55100 Lucca, Italy
4 shared publications - Giorgio Baroldi
Institute of Clinical Physiology, National Research Council, Milan and Pisa, Italy
2 shared publications - Paola Colombo
De Gasperis" Cardio Center ASST Niguarda Metropolitan Hospital, Milan, Italy
2 shared publications
Latest Publications
- 16 September 2010
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 17 (1) , 32-39
Understanding coronary atherosclerosis in relation to obesity: is getting the distribution of body fatness using dual-energy X-ray absorptiometry worth the effort? A novel perspective using Bayesian Networks
A relative excess of fat in the upper body region has been proven to be associated with increased coronary artery disease (CAD) risk. Dual-energy X-ray absorptiometry (DXA) is probably the most accurate and precise method available to study fat regional distribution and to directly measure total body fat and lean soft tissue mass. However, while several studies have investigated the abilities of obesity anthropometric measures in predicting CAD, only few studies have evaluated DXA as CAD predictor; particularly, a comparison between a model including information coming from anthropometric measurements and a model in which fat is precisely measured by DXA, is still lacking. In order to verify if CAD severity, as measured by Gensini score, is better predicted when a prognostic model includes DXA measurements rather than anthropometric measures, we compared performance obtained by two Bayesian Networks (BNs) including standard anthropometric measures and DXA, respectively. Data come from 58 consecutive patients, 79% of them having suspected and 21% known CAD. Two BNs were implemented: input variables include anamnestic information, biochemical data and obesity measures. In the first model (BN1) obesity was measured by body mass index and waist-to-hip ratio, while in the second one (BN2) it is quantified by DXA-derived parameters. Network graphs and results coming from sensitivity analysis show that in both models lipoproteins and biomarkers of inflammation act as proximal node, while obesity (independently of the chosen measure) appears to be a distal node acting by the intermediation of other variables. Both models show high predictive abilities, the mean percentage classification errors being, respectively, 14.13 and 18.87. In our study, the BN predictive ability is slightly superior when obesity is measured using anthropometric data instead of DXA measurements. The reason probably relies on the fact that in the BN the obesity role in predicting CAD is mediated by the action of other factors that appear to be more directly influencing the outcome. Thus, the necessity to dispose of a perfect measure becomes less compulsory and the huge effort to precisely estimate body composition with complex methods as DXA could be avoided when using expert system such as BN as predictive tool.
- 16 September 2010
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 17 (1) , 32-39
Understanding coronary atherosclerosis in relation to obesity: is getting the distribution of body fatness using dual-energy X-ray absorptiometry worth the effort? A novel perspective using Bayesian Networks
A relative excess of fat in the upper body region has been proven to be associated with increased coronary artery disease (CAD) risk. Dual-energy X-ray absorptiometry (DXA) is probably the most accurate and precise method available to study fat regional distribution and to directly measure total body fat and lean soft tissue mass. However, while several studies have investigated the abilities of obesity anthropometric measures in predicting CAD, only few studies have evaluated DXA as CAD predictor; particularly, a comparison between a model including information coming from anthropometric measurements and a model in which fat is precisely measured by DXA, is still lacking. In order to verify if CAD severity, as measured by Gensini score, is better predicted when a prognostic model includes DXA measurements rather than anthropometric measures, we compared performance obtained by two Bayesian Networks (BNs) including standard anthropometric measures and DXA, respectively. Data come from 58 consecutive patients, 79% of them having suspected and 21% known CAD. Two BNs were implemented: input variables include anamnestic information, biochemical data and obesity measures. In the first model (BN1) obesity was measured by body mass index and waist-to-hip ratio, while in the second one (BN2) it is quantified by DXA-derived parameters. Network graphs and results coming from sensitivity analysis show that in both models lipoproteins and biomarkers of inflammation act as proximal node, while obesity (independently of the chosen measure) appears to be a distal node acting by the intermediation of other variables. Both models show high predictive abilities, the mean percentage classification errors being, respectively, 14.13 and 18.87. In our study, the BN predictive ability is slightly superior when obesity is measured using anthropometric data instead of DXA measurements. The reason probably relies on the fact that in the BN the obesity role in predicting CAD is mediated by the action of other factors that appear to be more directly influencing the outcome. Thus, the necessity to dispose of a perfect measure becomes less compulsory and the huge effort to precisely estimate body composition with complex methods as DXA could be avoided when using expert system such as BN as predictive tool.
- Open Access
- 14 December 2009
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 7 (1) , 57
Assessing functional mitral regurgitation with exercise echocardiography: rationale and clinical applications
Secondary or functional mitral regurgitation (FMR) represents an increasing feature of mitral valve disease characterized by abnormal function of anatomically normal leaflets in the context of the impaired function of remodelled left ventricles. The anatomic and pathophysiological basis of FMR are briefly analyzed; in addition, the role of exercise echocardiography for the assessment of FMR is discussed in view of its relevance to clinical practice.
- 14 December 2009
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 7 (1) , 57
Open AccessAssessing functional mitral regurgitation with exercise echocardiography: rationale and clinical applications
Secondary or functional mitral regurgitation (FMR) represents an increasing feature of mitral valve disease characterized by abnormal function of anatomically normal leaflets in the context of the impaired function of remodelled left ventricles. The anatomic and pathophysiological basis of FMR are briefly analyzed; in addition, the role of exercise echocardiography for the assessment of FMR is discussed in view of its relevance to clinical practice.
- 23 June 2008
- Published by Elsevier in International Journal of Cardiology
- Vol. 127 (1) , 64-69
The Stress-Recovery Index for the risk stratification of women with typical chest pain
- 23 June 2008
- Published by Elsevier in International Journal of Cardiology
- Vol. 127 (1) , 64-69
The Stress-Recovery Index for the risk stratification of women with typical chest pain
- Open Access
- 1 August 2007
- Published by Elsevier in The American Journal of Cardiology
- Vol. 100 (4) , 605-609
Comparison of the Prognostic Value of the Stress-Recovery Index Versus Standard Electrocardiographic Criteria in Patients With a Negative Exercise Electrocardiogram
- 1 August 2007
- Published by Elsevier in The American Journal of Cardiology
- Vol. 100 (4) , 605-609
Open AccessComparison of the Prognostic Value of the Stress-Recovery Index Versus Standard Electrocardiographic Criteria in Patients With a Negative Exercise Electrocardiogram
- Open Access
- 30 January 2007
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 5 (1) , 5
Ultrasound Imaging Versus Morphopathology in Cardiovascular Diseases: The Heart Failure
This review article summarizes the results of histopathological studies to assess heart failure in humans. Different histopathological features underlying the clinical manifestations of heart failure are reviewed. In addition, the present role of echocardiographic techniques in assessing the failing heart is briefly summarized.
- 30 January 2007
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 5 (1) , 5
Open AccessUltrasound Imaging Versus Morphopathology in Cardiovascular Diseases: The Heart Failure
This review article summarizes the results of histopathological studies to assess heart failure in humans. Different histopathological features underlying the clinical manifestations of heart failure are reviewed. In addition, the present role of echocardiographic techniques in assessing the failing heart is briefly summarized.
- 1 November 2005
- Published by Elsevier in The American Journal of Cardiology
- Vol. 96 (9) , 1233-1236
Relation of Terminal QRS Distortion to Left Ventricular Functional Recovery and Remodeling in Acute Myocardial Infarction Treated With Primary Angioplasty
- 1 November 2005
- Published by Elsevier in The American Journal of Cardiology
- Vol. 96 (9) , 1233-1236
Relation of Terminal QRS Distortion to Left Ventricular Functional Recovery and Remodeling in Acute Myocardial Infarction Treated With Primary Angioplasty
- Open Access
- 6 October 2005
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 3 (1) , 32
Ultrasound imaging versus morphopathology in cardiovascular diseases. Myocardial cell damage
This review article summarizes the results of histopathological and clinical imaging studies to assess myocardial necrosis in humans. Different histopathological features of myocardial cell necrosis are reviewed. In addition, the present role of echocardiographic techniques in assessing irreversible myocardial damage is briefly summarized.
- 6 October 2005
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 3 (1) , 32
Open AccessUltrasound imaging versus morphopathology in cardiovascular diseases. Myocardial cell damage
This review article summarizes the results of histopathological and clinical imaging studies to assess myocardial necrosis in humans. Different histopathological features of myocardial cell necrosis are reviewed. In addition, the present role of echocardiographic techniques in assessing irreversible myocardial damage is briefly summarized.
- Open Access
- 2 September 2005
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 3 (1) , 25
Complications during pharmacological stress echocardiography: a video-case series
Background: Stress echocardiography is a cost-effective tool for the modern noninvasive diagnosis of coronary artery disease. Several physical and pharmacological stresses are used in combination with echocardiographic imaging, usually exercise, dobutamine and dipyridamole. The safety of a stress is (or should be) a major determinant in the choice of testing. Although large scale single center experiences and multicenter trial information are available for both dobutamine and dipyridamole stress echo testing, complications or side effects still can occur even in the most experienced laboratories with the most skilled operators. Case presentation: We decided to present a case collection of severe complications during pharmacological stress echo testing, including a ventricular tachycardia, cardiogenic shock, transient ischemic attack, torsade de pointe, fatal ventricular fibrillation, and free wall rupture. Conclusion: We believe that, in this field, every past complication described is a future complication avoided; what happens in your lab is more true of what you read in journals; and Good Clinical Practice is not "not having complications", but to describe the complications you had.
- 2 September 2005
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 3 (1) , 25
Open AccessComplications during pharmacological stress echocardiography: a video-case series
Background: Stress echocardiography is a cost-effective tool for the modern noninvasive diagnosis of coronary artery disease. Several physical and pharmacological stresses are used in combination with echocardiographic imaging, usually exercise, dobutamine and dipyridamole. The safety of a stress is (or should be) a major determinant in the choice of testing. Although large scale single center experiences and multicenter trial information are available for both dobutamine and dipyridamole stress echo testing, complications or side effects still can occur even in the most experienced laboratories with the most skilled operators. Case presentation: We decided to present a case collection of severe complications during pharmacological stress echo testing, including a ventricular tachycardia, cardiogenic shock, transient ischemic attack, torsade de pointe, fatal ventricular fibrillation, and free wall rupture. Conclusion: We believe that, in this field, every past complication described is a future complication avoided; what happens in your lab is more true of what you read in journals; and Good Clinical Practice is not "not having complications", but to describe the complications you had.
- 1 July 2005
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 23 (7) , 1409-1415
Simultaneous echocardiography and myocardial perfusion single photon emission computed tomography associated with dobutamine stress to predict long-term cardiac mortality in normotensive and hypertensive patients
Echocardiography and myocardial scintigraphy associated with dobutamine stress are used for assessing risk in coronary artery disease. We compared the accuracy of the two modalities applied simultaneously for predicting long-term cardiac mortality in normotensive and hypertensive patients. Three hundred and fifty-one consecutive patients underwent dobutamine stress with simultaneous echocardiography and 99mTc-sestamibi single photon emission computed tomography (SPECT). Fifty patients underwent early (<60 days) revascularization and were excluded; the analysis is based on 301 patients (131 hypertensives and 170 normotensives). The prevalence of additional risk factors, heart failure, prior myocardial infarction and prior revascularization was similar in the two groups of patients. An abnormal stress echocardiogram was detected in 101 (59%) normotensives and 80 (61%) hypertensives (NS), while 113 (66%) normotensives and 83 (63%) hypertensives (NS) showed abnormal myocardial perfusion. The agreement was 81% (kappa = 0.59) in hypertensives and 82% (kappa = 0.62) in normotensives. During 7.3 ± 2.8 years of follow-up, 17 (13%) hypertensives and 26 (15%) normotensives died from cardiac causes (P = 0.62). In normotensives, the annual mortality rate was 0.8 for normal echo and 1.3 for normal scan, 2.8 for abnormal echo and 2.6 for abnormal scan. In hypertensives, it was 0.5 for normal echo, 0% for normal scan, 2.6 for abnormal echo and 2.8 for abnormal scan. Each test was associated with higher survival in the case of negative compared to positive results in both normotensive and hypertensive patients (log-rank chi-square 16.4, P < 0.001). Dobutamine stress echocardiography and SPECT are equally effective in predicting long-term cardiac death in both normotensive and hypertensive patients.
- 1 July 2005
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 23 (7) , 1409-1415
Simultaneous echocardiography and myocardial perfusion single photon emission computed tomography associated with dobutamine stress to predict long-term cardiac mortality in normotensive and hypertensive patients
Echocardiography and myocardial scintigraphy associated with dobutamine stress are used for assessing risk in coronary artery disease. We compared the accuracy of the two modalities applied simultaneously for predicting long-term cardiac mortality in normotensive and hypertensive patients. Three hundred and fifty-one consecutive patients underwent dobutamine stress with simultaneous echocardiography and 99mTc-sestamibi single photon emission computed tomography (SPECT). Fifty patients underwent early (<60 days) revascularization and were excluded; the analysis is based on 301 patients (131 hypertensives and 170 normotensives). The prevalence of additional risk factors, heart failure, prior myocardial infarction and prior revascularization was similar in the two groups of patients. An abnormal stress echocardiogram was detected in 101 (59%) normotensives and 80 (61%) hypertensives (NS), while 113 (66%) normotensives and 83 (63%) hypertensives (NS) showed abnormal myocardial perfusion. The agreement was 81% (kappa = 0.59) in hypertensives and 82% (kappa = 0.62) in normotensives. During 7.3 ± 2.8 years of follow-up, 17 (13%) hypertensives and 26 (15%) normotensives died from cardiac causes (P = 0.62). In normotensives, the annual mortality rate was 0.8 for normal echo and 1.3 for normal scan, 2.8 for abnormal echo and 2.6 for abnormal scan. In hypertensives, it was 0.5 for normal echo, 0% for normal scan, 2.6 for abnormal echo and 2.8 for abnormal scan. Each test was associated with higher survival in the case of negative compared to positive results in both normotensive and hypertensive patients (log-rank chi-square 16.4, P < 0.001). Dobutamine stress echocardiography and SPECT are equally effective in predicting long-term cardiac death in both normotensive and hypertensive patients.